Brief: Pure Biologics Gets Approval To Obtain Research Material
March 20 (Reuters) - Pure Biologics SA PUR1.WA :
* SAYS GETS APPROVAL FROM BIOETHICAL COMMISSION TO OBTAIN
RESEARCH
MATERIAL FROM PATIENTS WITH NMO DISEASE
* OBTAINING RESEARCH MATERIAL IS PART OF APTAPHERESIS
(PB002)
PROJECT TO BE CONDUCTED IN 2018-2021
* APPROVAL OF COMMISSION GIVES OPPORTUNITY FOR CO TO USE
OBTAINED
MATERIAL IN FURTHER PHASES OF PROJECT
Source text for Eikon: ID:nEM8Yp3cTa
Further company coverage: PUR1.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48587720920;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects